Prostate Cancer Metastatic Disease Clinical Trials
0 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 2
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Prostate CancerProstate CarcinomaProstate Neoplasm+12 more
Shehzad Basaria, M.D.60 enrolled1 locationNCT06957691
Recruiting
Phase 2
Using FAPI PET/MRI to Evaluate Prostate Cancer
Prostate CancersProstate Cancer Metastatic Disease
University of Wisconsin, Madison30 enrolled1 locationNCT06675357
Recruiting
Phase 2
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
Prostate Cancer SurgeryProstate Cancer Metastatic Disease
Clinton Bahler22 enrolled3 locationsNCT06849544
Recruiting
Not Applicable
PSMA PET for Surveillance After Focal Therapy
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic DiseaseProstate Cancer (Diagnosis)
University of Chicago62 enrolled1 locationNCT07115914
Recruiting
Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer
Prostate Cancer Metastatic Disease
University Hospital, Grenoble130 enrolled1 locationNCT06828263
Recruiting
Not Applicable
Role of Race in Nutritional Approach in Men on ADT
Prostate Cancer Metastatic Disease
University of California, Los Angeles70 enrolled2 locationsNCT06682390
Recruiting
Phase 1Phase 2
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease
Halda Therapeutics OpCo, Inc.33 enrolled11 locationsNCT06800313
Recruiting
Phase 2
Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC
Prostate Cancer Metastatic Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School144 enrolled1 locationNCT06992232